InnoCare Pharma Limited (9969.HK)

HKD 6.1

(0.16%)

Gross Profit Summary of InnoCare Pharma Limited

InnoCare Pharma Limited's latest annual gross profit in 2023 was 610.1 Million CNY , up 26.58% from previous year.
InnoCare Pharma Limited's latest quarterly gross profit in 2024 Q1 was 141.53 Million CNY , down -18.48% from previous quarter.
InnoCare Pharma Limited reported a annual gross profit of 482 Million CNY in annual gross profit 2022, down -50.68% from previous year.
InnoCare Pharma Limited reported a annual gross profit of 977.36 Million CNY in annual gross profit 2021, up 71554.4% from previous year.
InnoCare Pharma Limited reported a quarterly gross profit of 218.06 Million CNY for 2024 Q2, up 54.07% from previous quarter.
InnoCare Pharma Limited reported a quarterly gross profit of 610.1 Million CNY for 2023 FY, up 26.58% from previous quarter.

Annual Gross Profit Chart of InnoCare Pharma Limited (2023 - 2017)

Historical Annual Gross Profit of InnoCare Pharma Limited (2023 - 2017)

Year	Gross Profit	Gross Profit Growth
2023	610.1 Million CNY	26.58%
2022	482 Million CNY	-50.68%
2021	977.36 Million CNY	71554.4%
2020	1.36 Million CNY	9.38%
2019	1.24 Million CNY	-22.88%
2018	1.61 Million CNY	1485.29%
2017	102 Thousand CNY	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	141.53 Million CNY	-18.48%
2024 Q2	218.06 Million CNY	54.07%
2023 FY	610.1 Million CNY	26.58%
2023 Q4	173.61 Million CNY	28.6%
2023 Q3	135 Million CNY	-12.89%
2023 Q1	146.49 Million CNY	4.55%
2023 Q2	154.98 Million CNY	5.8%
2022 Q4	140.11 Million CNY	-11.7%
2022 Q3	158.67 Million CNY	71.07%
2022 Q2	92.75 Million CNY	2.52%
2022 Q1	90.46 Million CNY	166.82%
2022 FY	482 Million CNY	-50.68%
2021 Q1	45.91 Million CNY	14807.95%
2021 Q3	851.62 Million CNY	1754.73%
2021 Q4	33.9 Million CNY	-96.02%
2021 Q2	45.91 Million CNY	0.0%
2021 FY	977.36 Million CNY	71554.4%
2020 FY	1.36 Million CNY	9.38%
2020 Q1	374 Thousand CNY	-8.33%
2020 Q3	308 Thousand CNY	-17.65%
2020 Q2	374 Thousand CNY	0.0%
2020 Q4	308 Thousand CNY	0.0%
2019 Q3	246 Thousand CNY	-17.03%
2019 Q2	296.5 Thousand CNY	0.0%
2019 Q1	296.5 Thousand CNY	-58.93%
2019 FY	1.24 Million CNY	-22.88%
2019 Q4	408 Thousand CNY	65.85%
2018 Q3	331 Thousand CNY	17.38%
2018 Q4	722 Thousand CNY	118.13%
2018 Q1	282 Thousand CNY	0.0%
2018 Q2	282 Thousand CNY	0.0%
2018 FY	1.61 Million CNY	1485.29%
2017 FY	102 Thousand CNY	0.0%

Peer Gross Profit Comparison of InnoCare Pharma Limited

Name	Gross Profit	Gross Profit Difference
Uni-Bio Science Group Limited	392.81 Million HKD	-55.314%
CK Life Sciences Int'l., (Holdings) Inc.	947.7 Million HKD	35.623%